[go: up one dir, main page]

DZ2311A1 - Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. - Google Patents

Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.

Info

Publication number
DZ2311A1
DZ2311A1 DZ970161A DZ970161A DZ2311A1 DZ 2311 A1 DZ2311 A1 DZ 2311A1 DZ 970161 A DZ970161 A DZ 970161A DZ 970161 A DZ970161 A DZ 970161A DZ 2311 A1 DZ2311 A1 DZ 2311A1
Authority
DZ
Algeria
Prior art keywords
preparation
degenerative diseases
benzopyran derivatives
medicaments against
against degenerative
Prior art date
Application number
DZ970161A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2311A1 publication Critical patent/DZ2311A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DZ970161A 1996-09-18 1997-09-17 Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. DZ2311A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
DZ2311A1 true DZ2311A1 (fr) 2002-12-28

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970161A DZ2311A1 (fr) 1996-09-18 1997-09-17 Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.

Country Status (30)

Country Link
EP (1) EP0939630B1 (fr)
JP (1) JP2001500520A (fr)
KR (1) KR20000036184A (fr)
CN (1) CN1230885A (fr)
AP (1) AP9901473A0 (fr)
AR (1) AR008838A1 (fr)
AT (1) ATE270102T1 (fr)
AU (1) AU730465B2 (fr)
BG (1) BG103252A (fr)
BR (1) BR9712030A (fr)
CA (1) CA2266681A1 (fr)
DE (1) DE69729735T2 (fr)
DZ (1) DZ2311A1 (fr)
EA (1) EA199900306A1 (fr)
ES (1) ES2223075T3 (fr)
GB (1) GB9619492D0 (fr)
HU (1) HUP9904638A3 (fr)
ID (2) ID23175A (fr)
IL (1) IL128786A0 (fr)
MA (1) MA24321A1 (fr)
NO (1) NO991292L (fr)
NZ (1) NZ334271A (fr)
OA (1) OA10998A (fr)
PE (1) PE109898A1 (fr)
PL (1) PL332313A1 (fr)
SK (1) SK35199A3 (fr)
TR (1) TR199900527T2 (fr)
UY (1) UY24717A1 (fr)
WO (1) WO1998011890A1 (fr)
ZA (1) ZA978359B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
JP2011522031A (ja) * 2008-06-05 2011-07-28 ミンスター・リサーチ・リミテッド 新規な治療
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
EA025824B1 (ru) 2009-07-27 2017-02-28 Джилид Сайэнс, Инк. Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EP2506847A1 (fr) * 2009-12-03 2012-10-10 Proximagen Limited Traitement de maladies infectieuses
AU2010325756A1 (en) * 2009-12-03 2012-06-21 Proximagen Ltd Treatment of allodynia and hyperalgesia
ES2529119T3 (es) 2010-07-02 2015-02-17 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (fr) 2011-07-01 2018-04-28
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
SG67930A1 (en) * 1994-06-10 1999-10-19 Smithkline Beecham Plc Benzopyrans and their use as therapeutic agents
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
HUP9904638A2 (hu) 2001-05-28
ES2223075T3 (es) 2005-02-16
EP0939630B1 (fr) 2004-06-30
OA10998A (en) 2003-03-04
EA199900306A1 (ru) 1999-08-26
ZA978359B (en) 1999-03-17
BR9712030A (pt) 1999-08-24
TR199900527T2 (xx) 1999-06-21
GB9619492D0 (en) 1996-10-30
KR20000036184A (ko) 2000-06-26
AR008838A1 (es) 2000-02-23
PE109898A1 (es) 1999-03-21
PL332313A1 (en) 1999-08-30
NO991292D0 (no) 1999-03-17
ID19542A (id) 1998-07-23
AU4704797A (en) 1998-04-14
HUP9904638A3 (en) 2001-08-28
ATE270102T1 (de) 2004-07-15
SK35199A3 (en) 2000-07-11
CN1230885A (zh) 1999-10-06
MA24321A1 (fr) 1998-04-01
JP2001500520A (ja) 2001-01-16
IL128786A0 (en) 2000-01-31
UY24717A1 (es) 2001-08-27
DE69729735D1 (de) 2004-08-05
AP9901473A0 (en) 1999-03-31
EP0939630A1 (fr) 1999-09-08
WO1998011890A1 (fr) 1998-03-26
NZ334271A (en) 2001-03-30
BG103252A (en) 1999-09-30
NO991292L (no) 1999-03-17
CA2266681A1 (fr) 1998-03-26
DE69729735T2 (de) 2005-07-14
AU730465B2 (en) 2001-03-08
ID23175A (id) 2000-03-23

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
AP9901677A0 (en) Substituted benzopyran derivatives for the treatment of inflammation
HUP0003311A3 (en) Substituted 6-phenylphenanthridine derivatives, pocess for producing them and pharmaceutical compositions containing them
ATE255117T1 (de) Aminophosphonsäure-derivate als arzneimittel
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
DZ2311A1 (fr) Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.
MX15184A (es) Procedimiento para la preparacion de derivados de isoindolinona,compuesto obtenido y medicamento quelo incluye.
AU7000796A (en) Heteroaryl-substituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
DZ2308A1 (fr) Procédés et intermédiaires pour la préparation de dérivés de chromanol substitués.
HUP0003398A3 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
HUP0004648A3 (en) 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
ZA97872B (en) Use of pyrolidine derivatives for the manufacture of medicaments.
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU6582098A (en) Medical splint product
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
HUP0000966A3 (en) Isoflavone derivatives and pharmaceutical compositions containing them
IL127690A0 (en) Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them